Upgrade to SI Premium - Free Trial

Xeris Pharmaceuticals Inc. (XERS)

7.99 +0.06 (0.76%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/6/26 *Est.)

Latest Headlines

Form 10-Q Xeris Biopharma Holdings For: Jun 30 August 6, 2026 4:11 PM - SEC Filing Form 8-K Xeris Biopharma Holdings For: Aug 06 August 6, 2026 7:13 AM - SEC Filing Xeris Pharmaceuticals Inc. (XERS) Misses Q2 EPS by 19c; Offers Guidance August 6, 2026 7:09 AM - StreetInsider Xeris Biopharma Reports Second Quarter 2026 Financial Results August 6, 2026 7:00 AM - BizWire Form 4 Xeris Biopharma Holdings For: Aug 03 Filed by: McCulloch Kevin August 4, 2026 5:30 PM - SEC Filing Form 4 Xeris Biopharma Holdings For: Aug 03 Filed by: Hecht Beth August 4, 2026 5:16 PM - SEC Filing Form SCHEDULE 13G Xeris Biopharma Holdings Filed by: VANGUARD CAPITAL MANAGEMENT LLC July 31, 2026 10:42 AM - SEC Filing Xeris Biopharma to Report Second Quarter 2026 Financial Results on August 6, 2026 July 23, 2026 7:30 AM - BizWire Form 8-K Xeris Biopharma Holdings For: Jul 15 July 17, 2026 4:21 PM - SEC Filing Form 4 Xeris Biopharma Holdings For: Jul 06 Filed by: Pieper Steven July 7, 2026 5:11 PM - SEC Filing Form 144 Xeris Biopharma Holdings Filed by: Pieper Steven July 7, 2026 4:38 PM - SEC Filing Form 144 Xeris Biopharma Holdings Filed by: Pieper Steven July 6, 2026 4:39 PM - SEC Filing CORRECTING and REPLACING Xeris Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) July 2, 2026 10:40 PM - BizWire Form 4 Xeris Biopharma Holdings For: Jul 01 Filed by: KREHER NERISSA July 2, 2026 6:02 PM - SEC Filing Form 3 Xeris Biopharma Holdings For: Jul 01 Filed by: KREHER NERISSA July 2, 2026 6:00 PM - SEC Filing Form 4 Xeris Biopharma Holdings For: Jul 01 Filed by: McCulloch Kevin July 2, 2026 4:41 PM - SEC Filing Form 4 Xeris Biopharma Holdings For: Jul 01 Filed by: Hecht Beth July 2, 2026 4:39 PM - SEC Filing Xeris Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) July 2, 2026 4:05 PM - BizWire Form 144 Xeris Biopharma Holdings Filed by: Hecht Beth July 1, 2026 4:51 PM - SEC Filing Form 144 Xeris Biopharma Holdings Filed by: McCulloch Kevin July 1, 2026 4:21 PM - SEC Filing Form 8-K Xeris Biopharma Holdings For: Jun 29 June 30, 2026 4:07 PM - SEC Filing Xeris names CEO John Shannon as board chair, adds new director June 30, 2026 7:00 AM - StreetInsider Xeris Announces Updates to Its Board of Directors June 30, 2026 7:00 AM - BizWire NASDAQ: XERS receives patent allowance for KEVEYIS extending protection to 2039 June 11, 2026 4:39 PM - StreetInsider Xeris Biopharma Announces Notice of Allowance From U.S. Patent and Trademark Office for New Patent Covering KEVEYIS® June 11, 2026 4:39 PM - BizWire Form 8-K Xeris Biopharma Holdings For: Jun 10 June 11, 2026 7:16 AM - SEC Filing Xeris Biopharma exchanges $23 million in convertible notes for cash and stock June 11, 2026 7:00 AM - StreetInsider Xeris Biopharma Announces Private Exchange of Convertible Notes June 11, 2026 7:00 AM - BizWire Form 4 Xeris Biopharma Holdings For: Jun 04 Filed by: Kong Garheng June 5, 2026 6:40 PM - SEC Filing Form 4 Xeris Biopharma Holdings For: Jun 03 Filed by: PERSKY MARLA June 5, 2026 6:29 PM - SEC Filing Form 4 Xeris Biopharma Holdings For: Jun 04 Filed by: HALKUFF DAWN June 5, 2026 6:18 PM - SEC Filing Form 4 Xeris Biopharma Holdings For: Jun 04 Filed by: BORMANN-KENNEDY BARBARA-JEAN ANNE June 5, 2026 6:18 PM - SEC Filing Form 4 Xeris Biopharma Holdings For: Jun 04 Filed by: JOHNSON JOHN June 5, 2026 6:18 PM - SEC Filing Form 4 Xeris Biopharma Holdings For: Jun 04 Filed by: Brady James Aloysius June 5, 2026 6:16 PM - SEC Filing Form 8-K Xeris Biopharma Holdings For: Jun 04 June 5, 2026 4:14 PM - SEC Filing Form 144 Xeris Biopharma Holdings Filed by: HALKUFF DAWN June 4, 2026 4:33 PM - SEC Filing Form 144 Xeris Biopharma Holdings Filed by: JOHNSON JOHN June 4, 2026 4:33 PM - SEC Filing Form 144 Xeris Biopharma Holdings Filed by: BORMANN-KENNEDY BARBARA-JEAN ANNE June 4, 2026 4:33 PM - SEC Filing Form 144 Xeris Biopharma Holdings Filed by: PERSKY MARLA June 3, 2026 4:26 PM - SEC Filing Form 4 Xeris Biopharma Holdings For: Jun 01 Filed by: Hecht Beth June 2, 2026 6:05 PM - SEC Filing Full Article List